Intellia Therapeutics
Sunanda Kannapadi is a Senior Research Associate at Intellia Therapeutics, Inc. Previously, Kannapadi worked at Magenta Therapeutics as a Research Associate in In Vitro Biology. Kannapadi has experience in validating company discovery platforms, designing flow cytometric experiments, and supporting NHP in vivo studies. Kannapadi has also worked at Northeastern University and Sri Ramachandra Institute Of Higher Education and Research, gaining experience in various research projects. Kannapadi holds a Master of Science degree in Biotechnology from Northeastern University.
Intellia Therapeutics
9 followers
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.